Top

BMC Cancer

Published in:

Open Access 01-12-2006 | Study protocol

Progressive resistance training and stretching following surgery for breast cancer: study protocol for a randomised controlled trial

Authors: Sharon L Kilbreath, Kathryn M Refshauge, Jane M Beith, Leigh C Ward, Judy M Simpson, Ross D Hansen

Published in: BMC Cancer | Issue 1/2006

Abstract

Background

Currently 1 in 11 women over the age of 60 in Australia are diagnosed with breast cancer. Following treatment, most breast cancer patients are left with shoulder and arm impairments which can impact significantly on quality of life and interfere substantially with activities of daily living. The primary aim of the proposed study is to determine whether upper limb impairments can be prevented by undertaking an exercise program of prolonged stretching and resistance training, commencing soon after surgery.

Methods/design

We will recruit 180 women who have had surgery for early stage breast cancer to a multicenter single-blind randomized controlled trial. At 4 weeks post surgery, women will be randomly assigned to either an exercise group or a usual care (control) group. Women allocated to the exercise group will perform exercises daily, and will be supervised once a week for 8 weeks. At the end of the 8 weeks, women will be given a home-based training program to continue indefinitely. Women in the usual care group will receive the same care as is now typically provided, i.e. a visit by the physiotherapist and occupational therapist while an inpatient, and receipt of pamphlets. All subjects will be assessed at baseline, 8 weeks, and 6 months later. The primary measure is arm symptoms, derived from a breast cancer specific questionnaire (BR23). In addition, range of motion, strength, swelling, pain and quality of life will be assessed.

Discussion

This study will determine whether exercise commencing soon after surgery can prevent secondary problems associated with treatment of breast cancer, and will thus provide the basis for successful rehabilitation and reduction in ongoing problems and health care use. Additionally, it will identify whether strengthening exercises reduce the incidence of arm swelling.

Trial Registration

The protocol for this study is registered with the Australian Clinical Trials Registry (ACTRN012606000050550).

Rietman JS, Dijkstra PU, Hoekstra HJ, Eisma WH, Szabo BG, Groothoff JW, Geertzen JH: Late morbidity after treatment of breast cancer in relation to daily activities and quality of life: a systematic review. Eur J Surg Oncol. 2003, 29 (3): 229-238. 10.1053/ejso.2002.1403.CrossRefPubMed

Westrup JL, Lash TL, Thwin SS, Silliman RA: Risk of decline in upper-body function and symptoms among older breast cancer patients. J Gen Intern Med. 2006, 21 (4): 327-333. 10.1111/j.1525-1497.2006.00384.x.CrossRefPubMedPubMedCentral

Collins LG, Nash R, Round T, Newman B: Perceptions of upper-body problems during recovery from breast cancer treatment. Support Care Cancer. 2004, 12 (2): 106-113. 10.1007/s00520-003-0554-5.CrossRefPubMed

Maunsell E, Brisson J, Deschenes L: Arm problems and psychological distress after surgery for breast cancer. Can J Surg. 1993, 36 (4): 315-320.PubMed

Engel J, Kerr J, Schlesinger-Raab A, Sauer H, Holzel D, Eckel R: Quality of life following breast-conserving therapy or mastectomy: results of a 5-year prospective study. Breast J. 2004, 10 (3): 223-231. 10.1111/j.1075-122X.2004.21323.x.CrossRefPubMed

Ivens D, Hoe AL, Podd TJ, Hamilton CR, Taylor I, Royle GT: Assessment of morbidity from complete axillary dissection. Br J Cancer. 1992, 66 (1): 136-138.CrossRefPubMedPubMedCentral

Kakuda JT, Stuntz M, Trivedi V, Klein SR, Vargas HI: Objective assessment of axillary morbidity in breast cancer treatment. Am Surg. 1999, 65 (10): 995-998.PubMed

Ernst MF, Voogd AC, Balder W, Klinkenbijl JH, Roukema JA: Early and late morbidity associated with axillary levels I-III dissection in breast cancer. J Surg Oncol. 2002, 79 (3): 151-155. 10.1002/jso.10061.CrossRefPubMed

Harris SR, Hugi MR, Olivotto IA, Levine M: Clinical practice guidelines for the care and treatment of breast cancer: 11. Lymphedema. CMAJ. 2001, 164 (2): 191-199.PubMedPubMedCentral

10.

Kilbreath SL, Refshauge KM, Beith J, Lee MJ: Resistance and stretching shoulder exercises early following axillary surgery for breast cancer,. Rehabilitation Oncology. 2006, 24 (2): 9 -14.

11.

McCredie MRE, Dite GS, Porter L, Maskiell J, Giles GG, Phillips KA, Redman S, Hopper JL: Prevalence of self-reported arm morbidity following treatment for breast cancer in the Australian Breast Cancer Family Study. Breast. 2001, 10 (6): 515-522. 10.1054/brst.2000.0291.CrossRefPubMed

12.

Shamley DR, Barker K, Simonite V, Beardshaw A: Delayed versus immediate exercises following surgery for breast cancer: a systematic review. Breast Cancer Res Treat. 2005, 90 (3): 263-271. 10.1007/s10549-004-4727-9.CrossRefPubMed

13.

Williams PE: Use of intermittent stretch in the prevention of serial sarcomere loss in immobilised muscle. Ann Rheum Dis. 1990, 49 (5): 316-317.CrossRefPubMedPubMedCentral

14.

Ada L, Goddard E, McCully J, Stavrinos T, Bampton J: Thirty minutes of positioning reduces the development of shoulder external rotation contracture after stroke: a randomized controlled trial. Arch Phys Med Rehabil. 2005, 86 (2): 230-234. 10.1016/j.apmr.2004.02.031.CrossRefPubMed

15.

Cornish BH, Bunce IH, Ward LC, Jones LC, Thomas BJ: Bioelectrical impedance for monitoring the efficacy of lymphoedema treatment programmes. Breast Cancer Res Treat. 1996, 38 (2): 169-176. 10.1007/BF01806671.CrossRefPubMed

16.

Noble BJ, Borg GA, Jacobs I, Ceci R, Kaiser P: A category-ratio perceived exertion scale: relationship to blood and muscle lactates and heart rate. Med Sci Sports Exerc. 1983, 15 (6): 523-528.CrossRefPubMed

17.

Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC, et al: The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993, 85 (5): 365-376.CrossRefPubMed

18.

Hjermstad MJ, Fossa SD, Bjordal K, Kaasa S: Test/retest study of the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire. J Clin Oncol. 1995, 13 (5): 1249-1254.PubMed

19.

Sprangers MA, Groenvold M, Arraras JI, Franklin J, te Velde A, Muller M, Franzini L, Williams A, de Haes HC, Hopwood P, Cull A, Aaronson NK: The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol. 1996, 14 (10): 2756-2768.PubMed

20.

Johansson K, Ingvar C, Albertsson M, Ekdahl C: Arm lymphoedema, shoulder mobility and muscle strength after breast cancer treatment -- a prospective 2-year study. Adv Physiother. 2001, 3 (2): 55-66.

21.

Nikkanen TA, Vanharanta H, Helenius-Reunanen H: Swelling of the upper extremity, function and muscle strength of shoulder joint following mastectomy combined with radiotherapy. Ann Clin Res. 1978, 10 (5): 273-279.PubMed

22.

Cornish BH, Chapman M, Hirst C, Mirolo B, Bunce IH, Ward LC, Thomas BJ: Early diagnosis of lymphedema using multiple frequency bioimpedance. Lymphology. 2001, 34 (1): 2-11.PubMed

23.

Tracey E, Roder D, Bishop J, Chen S, Chen W: Cancer in New South Wales: Incidence and mortality 2003. 2005, NSW Central Cancer Registry, Cancer Institute NSW

24.

Husen M, Paaschburg B, Flyger HL: Two-step axillary operation increases risk of arm morbidity in breast cancer patients. Breast. 2006

25.

Verhagen AP, de Vet HC, de Bie RA, Kessels AG, Boers M, Bouter LM, Knipschild PG: The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus. J Clin Epidemiol. 1998, 51 (12): 1235-1241. 10.1016/S0895-4356(98)00131-0.CrossRefPubMed

The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2407/6/273/prepub

Title: Progressive resistance training and stretching following surgery for breast cancer: study protocol for a randomised controlled trial
Authors: Sharon L Kilbreath
Kathryn M Refshauge
Jane M Beith
Leigh C Ward
Judy M Simpson
Ross D Hansen
Publication date: 01-12-2006
Publisher: BioMed Central
Published in: BMC Cancer / Issue 1/2006
Electronic ISSN: 1471-2407
DOI: https://doi.org/10.1186/1471-2407-6-273

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods/design

Discussion

Trial Registration

Please log in to get access to this content

Other articles of this Issue 1/2006

Comparative evaluation of the treatment efficacy of suberoylanilide hydroxamic acid (SAHA) and paclitaxel in ovarian cancer cell lines and primary ovarian cancer cells from patients

Erratum to: a method to estimate cell cycle time and growth fraction using bromodeoxyuridine-flow cytometry data from a single sample

Prevalence of the use of cancer related self-tests by members of the public: a community survey

The role of sialomucin CD164 (MGC-24v or endolyn) in prostate cancer metastasis

Inverse association of antioxidant and phytoestrogen nutrient intake with adult glioma in the San Francisco Bay Area: a case-control study

Down-regulation of transcription elogation factor A (SII) like 4 (TCEAL4) in anaplastic thyroid cancer

Keynote webinar | Spotlight on antibody–drug conjugates in cancer